An Assay for Cryptic Tumor Antigens in Sera of Women with Breast Cancer

  • R. Kinders
  • J. Slota
  • J. Patrick
  • C. Plate
  • I. Kafer
  • W. Caminiti
  • H. Rittenhouse
  • G. Manderino

Abstract

The utility of circul ating mucins as breast cancer markers was first proposed by Ceriani, et al. (1) and was rapidly confirmed and expanded by many other laboratories, including those of Chu, Taylor-Papadimitriou, Hilgers and Kufe (2–5). The antibodies used in mucin assays measure epitopes expressed on or cross-reactive with the human milk-fat globule membrane (HMFG) antigens. Assays using antibodies developed in many of the above mentioned laboratories are now commercially available, and have been used with some success in moni tori ng breast cancer patients.

Keywords

Breast Cancer Sialic Acid Benign Breast Disease Roswell Park Memorial Institute Neuraminidase Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    R. L. Ceriani, M. Sasaki, H. Sussman, W. M. Wara, and E. W. Blank, Circulating human mammary epithelial antigens in breast cancer, Proc. Natl. Acad. Sci. U. S. A. 79:5420–5424 (1982).PubMedCrossRefGoogle Scholar
  2. 2.
    J. Burchell, D. Wang, and J. Taylor-Papadimitriou, Detection of tumor-associated antigens recognized by the monoclonal anti bodi es HMFG-1 and 2 in serum from patients with breast cancer, Int. J. Cancer 34: 763–768 (1984).PubMedCrossRefGoogle Scholar
  3. 3.
    J. Hilkens, F. Buijs, J. Hilge rs, P. Hageman, J. Calafat, A. Sonnenberg, and M. van der Valk, Monoclonal antibodies against human milk-fat globule membranes detecting differentiationanti — gens of the mammarygland and its tumors, Int. J. Cancer 34:197–206 (1984).PubMedCrossRefGoogle Scholar
  4. 4.
    L. D. Papsidero, T. Nemoto, G. A. Croghan, and T. M. Chu, Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22, Cancer Res. 44:4653–4657 (1984).PubMedGoogle Scholar
  5. 5.
    D. F. Hayes, T. Ohno, M. Abe, H. Sekine, and D. W. Kufe, Detection of elevated plasma DF3 levels in breast cancer patients, J. Clin. Invest. 75:1671–1678 (1985).PubMedCrossRefGoogle Scholar
  6. 6.
    S. -I. Hakamori, Tumor-associated carbohydrate antigens, Ann. Rev. Immunol. 2:103–126 (1984).CrossRefGoogle Scholar
  7. 7.
    H. G. Rittenhouse, G. L. Manderino, and G. M. Hass, Mucin-type glycoproteins as tumor markers, Lab. Med. 16:556–560 (1985).Google Scholar
  8. 8.
    D. M. Swallow, B. Griffiths, M. Bramwell, G. Wiseman, and J. Burchell, Detection of the urinary PUM polymophism by the tumorbinding monoclonal anti bodies Ca1, Ca2, Ca3, HMFG1 and HMFG2, Disease Markers 4:247–254 (1986).PubMedGoogle Scholar
  9. 9.
    J. L. Magnani, Z. Steplewski, H. Koprowski, and V. Ginsburg, Identification of the gastrointestinal and pancreatic cancerassoci ated antigen detected by monoclonal antibody 19–9 in the sera of patients as a mucin, Cancer Res. 43:5489–5492 (1983).PubMedGoogle Scholar
  10. 10.
    L. D. Papsidero, G. A. Croghan, E. A. Johnson, and T. M. Chu, Immunoaffinityisolation of ductal carcinoma antigen using monoclonal antibody F36/22, Molec. Immunol. 21:955–960 (1984).CrossRefGoogle Scholar
  11. 11.
    B. Anderson, J. Slota, S. Kundu, J. Patrick, G. Manderino, H. Rittenhouse, and J. Tomita, Characteri zation of monoclonal anti — bodies to paragloboside and sialosyl-PG, and an improved chromatogram binding assay for rapidlyidentifying antibodies to tumor antigens, J. Cell Biochem. Suppl. 110:157 (1987).Google Scholar
  12. 12.
    M. M. Burger, A difference in the architecture of the surface membrane of normal and virally transformed cells, Proc. Natl. Acad. Sci. U. S. A., 62: 994–1001 (1969).PubMedCrossRefGoogle Scholar
  13. 13.
    G. F. Springer, T and Tn, general carcinoma antigens, Science 224:1198–1206 (1984).PubMedCrossRefGoogle Scholar
  14. 14.
    H. C. Gooi, K. -I. Uemura, P. Edwards, C. S. Foster, N. Pickering, and T. Feizi, Two mouse hybridoma antibodies against human milkfat globules recognize the I(MA) anti geni c determinant, Carbohydrate Res. 120:293–302 (1983).CrossRefGoogle Scholar
  15. 15.
    L. D. Papsidero, G. A. Croghan, M. J. O’Connel l, L. A. Valenzuela, T. Nemoto, and T. M. Chu, Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma, Cancer Res. 43:1742–1747 (1983).Google Scholar
  16. 16.
    T. Feizi and R. A. Childs, Carbohydrates as antigenic determinants of glycoproteins, Biochem. J. 245:1–11 (1987).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • R. Kinders
    • 1
  • J. Slota
    • 1
  • J. Patrick
    • 1
  • C. Plate
    • 1
  • I. Kafer
    • 1
  • W. Caminiti
    • 1
  • H. Rittenhouse
    • 1
  • G. Manderino
    • 1
  1. 1.Department 90C, RlBAbbott LaboratoriesNorth ChicagoUSA

Personalised recommendations